Herzig Shoshana J, Guess Jamey R, Feinbloom David B, Adra May, Afonso Kevin A, Howell Michael D, Marcantonio Edward R
Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts.
J Hosp Med. 2015 Jan;10(1):41-5. doi: 10.1002/jhm.2260.
As part of the Choosing Wisely Campaign, the Society of Hospital Medicine identified reducing inappropriate use of acid-suppressive medication for stress ulcer prophylaxis as 1 of 5 key opportunities to improve the value of care for hospitalized patients. We designed a computerized clinical decision support intervention to reduce use of acid-suppressive medication for stress ulcer prophylaxis in hospitalized patients outside of the intensive care unit at an academic medical center. Using quasiexperimental interrupted time series analysis, we found that the decision support intervention resulted in a significant reduction in use of acid-suppressive medication with stress ulcer prophylaxis selected as the only indication, a nonsignificant reduction in overall use, and no change in use on discharge. We found low rates of use of acid-suppressive medication for the purpose of stress ulcer prophylaxis even before the intervention, and continuing preadmission medication was the most commonly selected indication throughout the study. Our results suggest that attention should be focused on both the inpatient and outpatient settings when designing future initiatives to improve the appropriateness of acid-suppressive medication use.
作为“明智选择运动”的一部分,医院医学协会确定,减少用于应激性溃疡预防的抑酸药物的不当使用是提高住院患者护理价值的5个关键机会之一。我们设计了一项计算机化临床决策支持干预措施,以减少学术医疗中心重症监护室外住院患者用于应激性溃疡预防的抑酸药物的使用。通过准实验性中断时间序列分析,我们发现决策支持干预措施使仅选择应激性溃疡预防作为唯一适应症的抑酸药物使用显著减少,总体使用量有不显著减少,出院时的使用情况无变化。我们发现,即使在干预之前,用于应激性溃疡预防的抑酸药物使用率也很低,并且在整个研究过程中,继续使用入院前药物是最常选择的适应症。我们的结果表明,在设计未来举措以提高抑酸药物使用的适当性时,应同时关注住院和门诊环境。